More than a billion people worldwide suffer from one or more skin conditions, approximately 210 million people suffer from psoriasis (10 million in the U.S.). Unfortunately, in many cases there is no cure treatment. However, controlling the symptoms and appearance are a direct result of clinical trial studies. Since 1997 the Clinical Studies Division of the Wallace Skin Research Center has been engaged in its mission to find safe and effective treatments, and sometimes cures.
Wallace Skin Research Center has distinguished itself as a leader in dermatological clinical research studies in Southern California. We are proud to be one of the leading centers, specializing in bringing diversity to clinical studies. A high number of our participants are people of color, including persons of Asian, Black, Latino, and Middle Eastern descent. To achieve our mission, we rapidly pair study sponsors with prospective patients.
Once selected, study participants play a key role in helping to develop new and effective treatments, appropriate dosing, and technology to inhibit, alleviate, and possibly eradicate psoriasis and other skin conditions that have plagued mankind for centuries.